← Open Payments lookup

THOMAS DAVIS: Open Payments

NPI 1548320161 · OAKDALE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$243 in 15 payments from 6 companies in 2025. Trend: 2023 $329 · 2024 $224 · 2025 $243

Food & beverage: $243
CompanyPaymentsAmount
Lilly USA, LLC5$85
Novo Nordisk Inc5$76
Esperion Therapeutics, Inc.2$34
AstraZeneca Pharmaceuticals LP1$17
Vanda Pharmaceuticals Inc.1$16
ABBVIE INC.1$15

Products named: MOUNJARO, Ozempic, NEXLETOL, JARDIANCE, BREZTRI, FANAPT, VRAYLAR, Rybelsus.

Industry payments across LA — which companies pay providers there.